We can see that BLA is going to be accepted because there is no run up in the stock price and no hyping. If the hedgies knew it wasnt going to be approved they would be running the stock up again to short it like last time.
Big money pharma is keeping stock price down to keep leverage and pressure on partnership negotiations.
This is what the status quo does to all upcoming breakthrough therapies that did not partner early.
On another note the fda has been changing regulations to approve new drugs much quicker using real world evidence and comparing trials to previous outcomes for the disease being studied.
Billions of $$ has been going into cell therapy manufacturing.(Very positive)
Big money status quo succeeded in delaying these new drugs therapies for 10 years and that was their goal. Once big pharma discovered the cells acually worked they started attacking the manufacturing of the cells. And the hetroginity..They wanted the cell therapy company to prove that every dose of live cells was going to be exactly the same. Like you were producing some stamped pill. Well
These therapies should have been made available 7 years ago.
But now Biden is setting the stage with fda to bring this to fruition .... Cancer moonshoot is something he feels would be his greatest achievement. Cancer moonshoot is going to be conquered with dendretic cell therapy (dcvax) at the forefront along with combination therapies. The news from success in cancer will set the stage for cell therapies to get some traction.
All the best to you my Ozzy friends. Cant wait to come over and celebrate
- Forums
- ASX - By Stock
- MSB
- MSB 2023 - awaiting for Ryoncil approval
MSB 2023 - awaiting for Ryoncil approval, page-496
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 20225 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 0.945 |
6 | 52140 | 0.940 |
8 | 92185 | 0.935 |
5 | 73150 | 0.930 |
4 | 51132 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 20225 | 5 |
0.955 | 42472 | 3 |
0.960 | 80775 | 4 |
0.965 | 57967 | 5 |
0.970 | 73641 | 5 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online